Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma
纵向基因组分析优化靶向治疗:BRAFV600突变转移性黑色素瘤患者的II期LOGIC 2试验结果
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-0254
Dummer, Reinhard; Sandhu, Shahneen; Miller, Wilson H Jr; Butler, Marcus O; Taylor, Matthew H; Heinzerling, Lucie; Blank, Christian U; Muñoz-Couselo, Eva; Burris, Howard A 3rd; Postow, Michael A; Chmielowski, Bartosz; Middleton, Mark R; Berking, Carola; Hassel, Jessica C; Gesierich, Anja Heike; Mauch, Cornelia; Kleha, Joseph F; Polli, Anna; Harney, Allison S; di Pietro, Alessandra; Ascierto, Paolo A